1. Insulin-Like Growth Factor 1 Receptor as a Therapeutic Target in Ewing Sarcoma: Lack of Consistent Upregulation or Recurrent Mutation and a Review of the Clinical Trial Literature. (28th January 2013) Authors: O'Neill, Alison; Shah, Nilay; Zitomersky, Naamah; Ladanyi, Marc; Shukla, Neerav; Üren, Aykut; Loeb, David; Toretsky, Jeffrey Other Names: Tsokos Maria Academic Editor. Journal: Sarcoma Issue: Volume 2013(2013) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P-117 Combination Therapy with Immunomodulator and Infliximab is Associated with Higher Infliximab Trough Levels and Decreased Likelihood of Antibody Formation. (February 2017) Authors: Zitomersky, Naamah; Chi, Lisa; Bender-Stern, Julia; Tollefson, Sophia; Naik, Snehal; Snapper, Scott; Bousvaros, Athos Journal: Inflammatory bowel diseases Issue: Volume 23(2017)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P073 RISK STRATIFICATION TO INCREASE VENOUS THROMBOEMBOLISM PROPHYLAXIS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE. (7th February 2019) Authors: Levine, Anne E; Chi, Lisa Y; Sobczyk, Patricia; Bousvaros, Athos; Trenor, Cameron C; Zitomersky, Naamah Journal: Inflammatory bowel diseases Issue: Volume 25(2019)Supplement 1 Page Start: S35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗